Find-Health-Articles.com - making medical research available to everyone
Research article summary (published Apr 2009):

Chronic treatment with monoamine oxidase-B inhibitors decreases cocaine reward in mice.

Full Abstract

RATIONALE AND OBJECTIVE: Whether monoamine oxidase inhibitors (MAOIs) can be used to suppress the reinforcing effect of cocaine remains unknown. This study was undertaken to examine effects of a long-term dosing regimen with selective MAOIs on cocaine and food reward. MATERIALS AND METHODS: Since single dose of clorgyline (2 mg/kg), deprenyl (1 mg/kg), and pargyline (10 mg/kg) did not acutely affect mouse locomotor activity, these doses were chosen to treat the male C57BL/6j mice on a daily basis. RESULTS: Fourteen consecutive days of pretreatments with clorgyline, deprenyl, or pargyline (one injection per day) did not affect natural reward-supported operant behavior, since acquisition of the lever pressing responses for food pellets under an FR-1 protocol did not differ among these drug- and saline-treated mice. Likewise, 24 consecutive days of pretreatments with clorgyline did not alter acquisition of the cocaine (0.3 mg/kg per infusion)-supported operant responses under an FR-1 protocol. In contrast, 24 days of pretreatments with deprenyl and pargyline abolished the cocaine-supported operant responses under a similar protocol. Twenty-four days of clorgyline treatment enhanced serotonin contents in striatum, nucleus accumbens, and frontal cortex. Frontal cortical 3,4-dihydroxyphenylacetic acid and 5-hydroxyindoleacidic acid concentrations were decreased following 24 days of pretreatments with deprenyl and pargyline. These changes were not evident in mice pretreated with clorgyline. CONCLUSIONS: We suggest that long-term treatments with MAO-B inhibitors may decrease cocaine-supported operant responses in cocaine-naïve mice by selectively decreasing frontal cortical metabolism of dopamine and serotonin.

 

Author information

Author/s: Ho, Ming-Che (MC); Cherng, Chianfang G (CG); Tsai, Yen-Ping N (YP); Chiang, Chih-Yuan (CY); Chuang, Jia-Ying (JY); Kao, Shu-Fang (SF); Yu, Lung (L);

Affiliation: Institute of Behavioral Medicine, National Cheng Kung University College of Medicine, Tainan, Taiwan, 70101, Republic of China.

Journal and publication information

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal: Psychopharmacology (Psychopharmacology (Berl)), published in Germany. (Language: eng)

Reference: 2009-Jul; vol 205 (issue 1) : pp 141-9

Dates: Created 2009/06/12; Completed 2009/09/02;

PMID: 19343328, status: MEDLINE (last retrieval date: 9/4/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Associated Chemicals: Dopamine Uptake Inhibitors (0) ; Monoamine Oxidase Inhibitors (0) ; 3,4-Dihydroxyphenylacetic Acid (102-32-9) ; Cocaine (50-36-2) ; Serotonin (50-67-9) ; Hydroxyindoleacetic Acid (54-16-0)

Related articles

These are the highest related articles currently in the database:

See 100+ related articles.

Related Article Map

3/30/2000
6/29/2008
Higher Relevance Score (100)
Lower Relevance Score (81)

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.

© Advanogy LLC 2003-2009 - All rights reserved. Terms of Use | Contact Us | Index